← Back to Patent Explorer
US4100271A Expired / Lapsed US ⏱️ 0.0 years remaining

Clear, water-miscible, liquid pharmaceutical vehicles and compositions which gel at body temperature for drug delivery to mucous membranes

Assignee: Iolab Corp
•
Filing: 1976-02-26
•
Granted: 1978-07-11
•
Expires: 1996-02-26
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Pharmaceutical vehicles for delivery of pharmacologically active chemical materials to mucous membranes, as well as pharmaceutically active compositions containing such vehicles, are provided. The pharmaceutical vehicles are clear, water-miscible, physiologically-acceptable, liquid compositions which gel to a thickened, non-flowing and adhering consistency at human body temperature. They are liquid at ambient room temperature and have a gel transition temperature in the range of from about 25° to about 40° C. Aqueous solutions of certain polyoxyethylene-polyoxypropylene condensates are suitable vehicles. Also provided are pharmaceutical compositions containing added pharmacologically active chemical material, i.e., a drug or medicament. A method of delivering the drug or medicament to a mucous membrane is also provided.

Inventors

  • 👤 Joseph Z. Krezanoski

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 22:21
CPC Classifications
A; A61; A61K; A61K47/00; A61K47/06; A61K47/08; A61K47/10; A61K47/02; A61K9/00; A61K9/0012; A61K9/0048; A61P; A61P27/00; A61P27/02

Claims Analysis

Total Claims: 20
Claim 1
Independent Claim 81 words
A method of therapeutically treating the symptoms of Sjogren's syndrome, ophthalmic edema and eye irritation in a mammal, comprising, topically administering to affected eyes of such mammal, a pharmaceutical composition which consists of a clear, water-miscible, physiologically acceptable, liquid composition which gels to a thickened, non-flowing and adhering consistency at human body temperature, the composition comprising an aqueous solution of a polyoxyethylenepolyoxypropylene block copolymer and having a gel transition temperature in the range of from about 25° to about 40° C.
Claim 2
Independent Claim 81 words
A method of therapeutically treating the symptoms of Sjogren's syndrome, ophthalmic edema and eye irritation in a mammal, comprising, topically administering to affected eyes of such mammal, a pharmaceutical composition which consists of a clear, water-miscible, physiologically acceptable, liquid composition which gels to a thickened, non-flowing and adhering consistency at human body temperature, the composition comprising an aqueous solution of a polyoxyethylenepolyoxypropylene block copolymer and having a gel transition temperature in the range of from about 25° to about 40° C.
Claim 3
Dependent Claim 20 words
A method according to claim 1 in which the pharmaceutical composition is applied to the affected eyes in drop form.
Claim 4
Dependent Claim 23 words
A method according to claim 1 in which the composition has a pH in the range of from about 6.2 to about 7.8.
Claim 5
Independent Claim 89 words
A method of medicinally treating a mucous membrane condition in need of pharmacologic treatment comprising contacting such mucous membrane with a clear, water-miscible, physiologically acceptable, liquid composition which gels to a thickened, non-flowing and adhering consistency after contact with the mucous membrane, the liquid composition comprising a pharmacologically effective amount of a chemical material which is pharmacologically active against said condition, and a pharmaceutical vehicle which is a clear, water-miscible, physiologically acceptable liquid having a gel transition temperature in the range of from about 25° to about 40° C.
Claim 6
Independent Claim 89 words
A method of medicinally treating a mucous membrane condition in need of pharmacologic treatment comprising contacting such mucous membrane with a clear, water-miscible, physiologically acceptable, liquid composition which gels to a thickened, non-flowing and adhering consistency after contact with the mucous membrane, the liquid composition comprising a pharmacologically effective amount of a chemical material which is pharmacologically active against said condition, and a pharmaceutical vehicle which is a clear, water-miscible, physiologically acceptable liquid having a gel transition temperature in the range of from about 25° to about 40° C.
Claim 7
Dependent Claim 23 words
A method according to claim 4 in which the composition has a pH in the range of from about 6.2 to about 7.8.
Claim 8
Dependent Claim 15 words
A method according to claim 4 in which the pharmacologically active chemical material is dexamethasone.
Claim 9
Dependent Claim 16 words
A method according to claim 4 in which the pharmacologically active chemical material is pilocarpine HCl.
Claim 10
Dependent Claim 15 words
A method according to claim 4 in which the pharmacologically active chemical material is phenylephrine.
Claim 11
Dependent Claim 17 words
A method according to claim 4 in which the pharmacologically active chemical material is an antimicrobial agent.
Claim 12
Dependent Claim 33 words
A method according to claim 9 in which the pharmacologically active chemical material is selected from the group consisting of clofazimine, pimaricin, amphotericin, neomycin sulfate, chloramphenicol, bacitracin, sulfacetamide, gentamycin, and polymixin B sulfate.
Claim 13
Dependent Claim 20 words
A method according to claim 4 in which the liquid composition is applied to the mucous membrane in drop form.
Claim 14
Independent Claim 87 words
A method of medicinally treating an eye condition in need of pharmacologic treatment comprising contacting the affected eye with a clear, water-miscible, physiologically acceptable, liquid composition which gels to a thickened, non-flowing adhering consistency after contact with the mucous membrane, the liquid composition comprising a pharmacologically effective amount of a chemical material which is pharmacologically active against said condition, and a pharmaceutical vehicle which is a clear, water-miscible, physiologically acceptable liquid having a gel transition temperature in the range of from about 25° to about 40° C.
Claim 15
Independent Claim 87 words
A method of medicinally treating an eye condition in need of pharmacologic treatment comprising contacting the affected eye with a clear, water-miscible, physiologically acceptable, liquid composition which gels to a thickened, non-flowing adhering consistency after contact with the mucous membrane, the liquid composition comprising a pharmacologically effective amount of a chemical material which is pharmacologically active against said condition, and a pharmaceutical vehicle which is a clear, water-miscible, physiologically acceptable liquid having a gel transition temperature in the range of from about 25° to about 40° C.
Claim 16
Dependent Claim 23 words
A method according to claim 12 in which the composition has a pH in the range of from about 6.2 to about 7.8.
Claim 17
Dependent Claim 15 words
A method according to claim 12 in which the pharmacologically active chemical material is dexamethasone.
Claim 18
Dependent Claim 22 words
A method according to claim 12 in which the pharmacologically active chemical material is pilocarpine HCl and the eye condition is glaucoma.
Claim 19
Dependent Claim 15 words
A method according to claim 12 in which the pharmacologically active chemical material is phenylephrine.
Claim 20
Dependent Claim 17 words
A method according to claim 12 in which the pharmacologically active chemical material is an antimicrobial agent.

References Cited (Backward Citations)

US2921885A Cited
US3240709A Cited
US3740421A Cited
US3639574A Cited
US3882036A Cited
US3867533A Cited
US3947573A Cited
US3767788A Cited
US3884826A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1981-07-10 1982-01-09 1982-07-11 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1985-07-10 1986-01-09 1986-07-11 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1989-07-10 1990-01-09 1990-07-11 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag